Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

Galectin-lattice sustains function of cationic amino acid transporter and insulin secretion of pancreatic β cells.

Maeda K, Tasaki M, Ando Y, Ohtsubo K.

J Biochem. 2020 Jan 21. pii: mvaa007. doi: 10.1093/jb/mvaa007. [Epub ahead of print]

PMID:
31960919
2.

Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade.

Nakao S, Arai Y, Tasaki M, Yamashita M, Murakami R, Kawase T, Amino N, Nakatake M, Kurosaki H, Mori M, Takeuchi M, Nakamura T.

Sci Transl Med. 2020 Jan 15;12(526). pii: eaax7992. doi: 10.1126/scitranslmed.aax7992.

PMID:
31941828
3.

Clinically relevant GSK‑3β inhibitor 9‑ING‑41 is active as a single agent and in combination with other antitumor therapies in human renal cancer.

Anraku T, Kuroki H, Kazama A, Bilim V, Tasaki M, Schmitt D, Mazar A, Giles FJ, Ugolkov A, Tomita Y.

Int J Mol Med. 2020 Feb;45(2):315-323. doi: 10.3892/ijmm.2019.4427. Epub 2019 Dec 12.

4.

9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer.

Kuroki H, Anraku T, Kazama A, Bilim V, Tasaki M, Schmitt D, Mazar AP, Giles FJ, Ugolkov A, Tomita Y.

Sci Rep. 2019 Dec 27;9(1):19977. doi: 10.1038/s41598-019-56461-4.

5.

Inherent Biophysical Properties Modulate the Toxicity of Soluble Amyloidogenic Light Chains.

Maritan M, Romeo M, Oberti L, Sormanni P, Tasaki M, Russo R, Ambrosetti A, Motta P, Rognoni P, Mazzini G, Barbiroli A, Palladini G, Vendruscolo M, Diomede L, Bolognesi M, Merlini G, Lavatelli F, Ricagno S.

J Mol Biol. 2019 Dec 24. pii: S0022-2836(19)30715-6. doi: 10.1016/j.jmb.2019.12.015. [Epub ahead of print]

PMID:
31874151
6.

Needle-shaped amyloid deposition in rat mammary gland: evidence of a novel amyloid fibril protein.

Murakami T, Noguchi K, Hachiya N, Kametani F, Tasaki M, Nakaba S, Sassa Y, Yamashita T, Obayashi K, Ando Y, Hamamura M, Kanno T, Kawasako K.

Amyloid. 2020 Mar;27(1):25-35. doi: 10.1080/13506129.2019.1675623. Epub 2019 Oct 15.

PMID:
31615282
7.

Analysis of the prevalence of systemic de novo thrombotic microangiopathy after ABO-incompatible kidney transplantation and the associated risk factors.

Tasaki M, Saito K, Nakagawa Y, Imai N, Ito Y, Yoshida Y, Ikeda M, Ishikawa S, Narita I, Takahashi K, Tomita Y.

Int J Urol. 2019 Dec;26(12):1128-1137. doi: 10.1111/iju.14118. Epub 2019 Oct 6.

PMID:
31587389
8.

Characteristics of acquired transthyretin amyloidosis: A case series and review of the literature.

Misumi Y, Ueda M, Masuda T, Tsuda Y, Nomura T, Okada M, Inoue Y, Tasaki M, Obayashi K, Yamashita T, Ando Y.

Neurology. 2019 Oct 22;93(17):e1587-e1596. doi: 10.1212/WNL.0000000000008360. Epub 2019 Sep 11. Review.

PMID:
31511348
9.

Transgenic expression of human CD47 reduces phagocytosis of porcine endothelial cells and podocytes by baboon and human macrophages.

Nomura S, Ariyoshi Y, Watanabe H, Pomposelli T, Takeuchi K, Garcia G, Tasaki M, Ayares D, Sykes M, Sachs D, Johnson R, Yamada K.

Xenotransplantation. 2020 Jan;27(1):e12549. doi: 10.1111/xen.12549. Epub 2019 Sep 8.

PMID:
31495971
10.

Serum diacron-reactive oxygen metabolites (d-ROMs) and biological antioxidant potential (BAP) in patients with ATTR-PN.

Obayashi K, Masuda T, Tasaki M, Ando Y, Ueda M.

Amyloid. 2019;26(sup1):65. doi: 10.1080/13506129.2019.1583183. No abstract available.

PMID:
31343364
11.

Evaluation of myoelectrical activities of descending colon by electrointestinogram in patients with ATTRm amyloidosis.

Obayashi K, Masuda T, Tasaki M, Ando Y, Ueda M.

Amyloid. 2019;26(sup1):66. doi: 10.1080/13506129.2019.1583184. No abstract available.

PMID:
31343362
12.

Reduced intraepidermal nerve fibre density in patients with hereditary transthyretin amyloidosis.

Masuda T, Ueda M, Misumi Y, Nomura T, Inoue Y, Isoguchi A, Kanenawa K, Tasaki M, Yamashita T, Sonoda Y, Obayashi K, Ando Y.

Amyloid. 2019;26(sup1):79-80. doi: 10.1080/13506129.2019.1583198. No abstract available.

PMID:
31343297
13.

Bortezomib Eliminates Plasma Cells From a Renal Graft in Plasma Cell-Rich Acute Rejection.

Tasaki M, Saito K, Nakagawa Y, Ikeda M, Imai N, Ito Y, Sudo M, Ikezumi Y, Yamada T, Hasegawa H, Kobayashi T, Miura K, Narita I, Takahashi K, Tomita Y.

Transplant Proc. 2019 Jul - Aug;51(6):1732-1738. doi: 10.1016/j.transproceed.2019.02.038. Epub 2019 Jul 10.

PMID:
31301858
14.

Simple, reliable detection of amyloid in fat aspirates using the fluorescent dye FSB: prospective study in 206 patients.

Tasaki M, Milani P, Foli A, Verga L, Obici L, Basset M, Bozzola M, Ferraro G, Nuvolone M, Morbini P, Capello G, Ueda M, Obayashi K, Paulli M, Ando Y, Merlini G, Palladini G, Lavatelli F.

Blood. 2019 Jul 18;134(3):320-323. doi: 10.1182/blood.2019000420. Epub 2019 Jun 6. No abstract available.

PMID:
31171502
15.

A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pH.

Ueda M, Okada M, Mizuguchi M, Kluve-Beckerman B, Kanenawa K, Isoguchi A, Misumi Y, Tasaki M, Ueda A, Kanai A, Sasaki R, Masuda T, Inoue Y, Nomura T, Shinriki S, Shuto T, Kai H, Yamashita T, Matsui H, Benson MD, Ando Y.

J Biol Chem. 2019 Jul 19;294(29):11259-11275. doi: 10.1074/jbc.RA119.007851. Epub 2019 Jun 5.

PMID:
31167790
16.

New simple and quick method to analyze serum variant transthyretins: direct MALDI method for the screening of hereditary transthyretin amyloidosis.

Nomura T, Ueda M, Tasaki M, Misumi Y, Masuda T, Inoue Y, Tsuda Y, Okada M, Okazaki T, Kanenawa K, Isoguchi A, Nakamura M, Obayashi K, Shinriki S, Matsui H, Yamashita T, Ando Y.

Orphanet J Rare Dis. 2019 May 27;14(1):116. doi: 10.1186/s13023-019-1100-y.

17.

Efficacy and safety of ribavirin therapy for chronic hepatitis E after kidney transplantation.

Yoshida T, Takamura M, Goto R, Takeuchi S, Tsuchiya A, Kamimura K, Tasaki M, Nakagawa Y, Saito K, Tomita Y, Terai S.

Hepatol Res. 2019 Oct;49(10):1244-1248. doi: 10.1111/hepr.13363. Epub 2019 May 30.

PMID:
31077507
18.

Low-Dose-Rate and High-Dose-Rate Brachytherapy for Localized Prostate Cancer in ABO-Incompatible Renal Transplant Recipients.

Tasaki M, Kasahara T, Kaidu M, Kawaguchi G, Hara N, Yamana K, Maruyama R, Takizawa I, Ishizaki F, Saito K, Nakagawa Y, Ikeda M, Umezu H, Nishiyama T, Aoyama H, Tomita Y.

Transplant Proc. 2019 Apr;51(3):774-778. doi: 10.1016/j.transproceed.2018.10.027. Epub 2019 Jan 9.

PMID:
30979463
19.

Retrospective Analysis to Determine the Optimal Timing to Discontinue Continuous Antibiotic Prophylaxis in Patients with Primary Vesicoureteral Reflux.

Anraku T, Obara K, Tasaki M, Tomita Y.

Urol Int. 2019;102(4):462-467. doi: 10.1159/000497312. Epub 2019 Mar 27.

PMID:
30917379
20.

Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient.

Swuec P, Lavatelli F, Tasaki M, Paissoni C, Rognoni P, Maritan M, Brambilla F, Milani P, Mauri P, Camilloni C, Palladini G, Merlini G, Ricagno S, Bolognesi M.

Nat Commun. 2019 Mar 20;10(1):1269. doi: 10.1038/s41467-019-09133-w.

21.

Limited significance of repeated long-term radiological and hormonal examination in nonfunctioning adrenal incidentalomas.

Tasaki M, Kasahara T, Takizawa I, Saito K, Nishiyama T, Tomita Y.

Int Braz J Urol. 2019 May-Jun;45(3):503-513. doi: 10.1590/S1677-5538.IBJU.2018.0235.

22.

Discovery of 2,4-diamino-5-cyanopyrimidine derivatives as protein kinase C theta inhibitors with mitigated time-dependent drug-drug interactions.

Kunikawa S, Tanaka A, Takasuna Y, Tasaki M, Chida N.

Bioorg Med Chem. 2019 Mar 1;27(5):790-799. doi: 10.1016/j.bmc.2019.01.019. Epub 2019 Jan 23.

PMID:
30704835
23.

ATR-FTIR Spectroscopy Supported by Multivariate Analysis for the Characterization of Adipose Tissue Aspirates from Patients Affected by Systemic Amyloidosis.

Ami D, Mereghetti P, Foli A, Tasaki M, Milani P, Nuvolone M, Palladini G, Merlini G, Lavatelli F, Natalello A.

Anal Chem. 2019 Feb 19;91(4):2894-2900. doi: 10.1021/acs.analchem.8b05008. Epub 2019 Feb 4.

PMID:
30676723
24.

[LONG-TERM OUTCOME OF PEDIATRIC KIDNEY TRANSPLANTATION: A SINGLE-CENTER EXPERIENCES].

Kuroki H, Tasaki M, Saito K, Nakagawa Y, Ikezumi Y, Suzuki T, Yamada T, Hasegawa H, Maruyama K, Imai N, Takahashi K, Tomita Y.

Nihon Hinyokika Gakkai Zasshi. 2018;109(1):14-19. doi: 10.5980/jpnjurol.109.14. Japanese.

25.

Method for Combined Observation of Serial Sections of Stented Arteries Embedded in Resin by Light Microscopy and Transmission Electron Microscopy.

Isobe A, Iwatani K, Souba J, Terao H, Hagiwara H, Kumagai F, Saito Y, Nagano K, Tasaki M.

Toxicol Pathol. 2019 Apr;47(3):401-407. doi: 10.1177/0192623318814726. Epub 2018 Dec 25.

PMID:
30585131
26.

Ice slurry ingestion during break times attenuates the increase of core temperature in a simulation of physical demand of match-play tennis in the heat.

Naito T, Sagayama H, Akazawa N, Haramura M, Tasaki M, Takahashi H.

Temperature (Austin). 2018 Sep 5;5(4):371-379. doi: 10.1080/23328940.2018.1475989. eCollection 2018.

27.

A novel age-related venous amyloidosis derived from EGF-containing fibulin-like extracellular matrix protein 1.

Tasaki M, Ueda M, Hoshii Y, Mizukami M, Matsumoto S, Nakamura M, Yamashita T, Ueda A, Misumi Y, Masuda T, Inoue Y, Torikai T, Nomura T, Tsuda Y, Kanenawa K, Isoguchi A, Okada M, Matsui H, Obayashi K, Ando Y.

J Pathol. 2019 Apr;247(4):444-455. doi: 10.1002/path.5203. Epub 2018 Dec 21.

PMID:
30565683
28.

Different Vascular Responses to a Bare Nitinol Stent in Porcine Femoral and Femoropopliteal Arteries.

Sakaoka A, Souba J, Rousselle SD, Matsuda T, Tellez A, Hagiwara H, Nagano K, Tasaki M.

Toxicol Pathol. 2019 Apr;47(3):408-417. doi: 10.1177/0192623318800726. Epub 2018 Oct 3.

PMID:
30282527
29.

A novel 2,4-diaminopyrimidine derivative as selective inhibitor of protein kinase C theta prevents allograft rejection in a rat heart transplant model.

Kunikawa S, Tanaka A, Takasuna Y, Tasaki M, Chida N.

Bioorg Med Chem. 2018 Nov 1;26(20):5499-5509. doi: 10.1016/j.bmc.2018.09.029. Epub 2018 Sep 24.

PMID:
30274941
30.

Muscle-dominant wild-type TDP-43 expression induces myopathological changes featuring tubular aggregates and TDP-43-positive inclusions.

Tawara N, Yamashita S, Kawakami K, Kurashige T, Zhang Z, Tasaki M, Yamamoto Y, Nishikami T, Doki T, Zhang X, Matsuo Y, Kimura E, Tawara A, Maeda Y, Hauschka SD, Maruyama H, Ando Y.

Exp Neurol. 2018 Nov;309:169-180. doi: 10.1016/j.expneurol.2018.08.006. Epub 2018 Aug 18.

PMID:
30130494
31.

SIRT7 has a critical role in bone formation by regulating lysine acylation of SP7/Osterix.

Fukuda M, Yoshizawa T, Karim MF, Sobuz SU, Korogi W, Kobayasi D, Okanishi H, Tasaki M, Ono K, Sawa T, Sato Y, Chirifu M, Masuda T, Nakamura T, Tanoue H, Nakashima K, Kobashigawa Y, Morioka H, Bober E, Ohtsuki S, Yamagata Y, Ando Y, Oike Y, Araki N, Takeda S, Mizuta H, Yamagata K.

Nat Commun. 2018 Jul 19;9(1):2833. doi: 10.1038/s41467-018-05187-4.

32.

Authors' Reply.

Kai M, Tasaki M, Chino N.

J Minim Invasive Gynecol. 2018 Nov - Dec;25(7):1311. doi: 10.1016/j.jmig.2018.05.019. Epub 2018 May 28. No abstract available.

PMID:
29852295
33.

Upregulation of CD80 on glomerular podocytes plays an important role in development of proteinuria following pig-to-baboon xeno-renal transplantation - an experimental study.

Rivard CJ, Tanabe T, Lanaspa MA, Watanabe H, Nomura S, Andres-Hernando A, Garth K, Sekijima M, Ishimoto T, Ariyoshi Y, Garcia GE, Shah J, Lennan B, Tasaki M, Pomposelli T, Shimizu A, Sachs DH, Johnson RJ, Yamada K.

Transpl Int. 2018 Oct;31(10):1164-1177. doi: 10.1111/tri.13273. Epub 2018 Jun 5.

34.

Chemoselective epoxidation of cholesterol derivatives on a surface-designed molecularly imprinted Ru-porphyrin catalyst.

Muratsugu S, Baba H, Tanimoto T, Sawaguchi K, Ikemoto S, Tasaki M, Terao Y, Tada M.

Chem Commun (Camb). 2018 May 15;54(40):5114-5117. doi: 10.1039/c8cc00896e.

PMID:
29717744
35.

Ombitasvir-Paritaprevir-Ritonavir Therapy in a Kidney Transplant Recipient With Chronic Hepatitis C Virus Genotype 1 Infection: A Case Report on the Importance of Considering Drug-Drug Interactions and Monitoring Cyclosporine Levels.

Takeuchi S, Takamura M, Yoshida T, Takahashi K, Hayashi K, Hashimoto S, Yamagiwa S, Tasaki M, Nakagawa Y, Saito K, Tanabe Y, Tomita Y, Terai S.

Transplant Proc. 2018 Apr;50(3):884-886. doi: 10.1016/j.transproceed.2018.01.006.

PMID:
29661458
36.

Management of Juvenile Idiopathic Arthritis in ABO-incompatible Kidney Transplantation: A Case Report.

Ishikawa S, Tasaki M, Kuroda T, Kobayashi D, Saito K, Nakagawa Y, Ikeda M, Takahashi K, Tomita Y.

Transplant Proc. 2018 Apr;50(3):869-872. doi: 10.1016/j.transproceed.2017.12.052.

PMID:
29661455
37.

Anxiety and depression associated with tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia.

Sogawa R, Kimura S, Yakabe R, Mizokami Y, Tasaki M, Sueoka-Aragane N, Narisawa Y, Kimura S.

Int J Clin Oncol. 2018 Oct;23(5):974-979. doi: 10.1007/s10147-018-1275-6. Epub 2018 Apr 12.

PMID:
29651584
38.

National survey of hospital child protection teams in Japan.

Tanoue K, Senda M, An B, Tasaki M, Taguchi M, Kobashi K, Oana S, Mizoguchi F, Shiraishi Y, Yamada F, Okuyama M, Ichikawa K.

Child Abuse Negl. 2018 May;79:11-21. doi: 10.1016/j.chiabu.2018.01.016. Epub 2018 Feb 6.

PMID:
29407852
39.

[THE USE OF BORTEZOMIB FOR THE TREATMENT OF CHRONIC ANTIBODY MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION].

Tasaki M, Saito K, Nakagawa Y, Nobushita T, Anraku T, Kuroki H, Imai N, Ito Y, Tomita Y.

Nihon Hinyokika Gakkai Zasshi. 2018;109(2):68-73. doi: 10.5980/jpnjurol.109.68. Japanese.

40.

Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan.

Yamashita T, Ueda M, Misumi Y, Masuda T, Nomura T, Tasaki M, Takamatsu K, Sasada K, Obayashi K, Matsui H, Ando Y.

J Neurol. 2018 Jan;265(1):134-140. doi: 10.1007/s00415-017-8640-7. Epub 2017 Nov 24.

PMID:
29177547
41.

Regional population differences of the brown planthopper (Nilaparvata lugens Stål) in Cambodia using genotyping-by-sequencing.

Matsukawa M, Tasaki M, Doi K, Ito K, Kawakita K, Tanaka T.

Bull Entomol Res. 2018 Aug;108(4):471-478. doi: 10.1017/S0007485317000992. Epub 2017 Oct 24.

PMID:
29061206
42.

Evaluation of a Spray-type, Novel Dextrin Hydrogel Adhesion Barrier Under Laparoscopic Conditions in a Porcine Uterine Horn Adhesion Model.

Kai M, Maeda K, Tasaki M, Kira S, Nakamura S, Chino N, Hagiwara H, Nishida H, Kawanishi T.

J Minim Invasive Gynecol. 2018 Mar - Apr;25(3):447-454. doi: 10.1016/j.jmig.2017.09.023. Epub 2017 Oct 10.

PMID:
29030291
43.

Infrared Spectroscopy and X-ray Diffraction Characterization of Dimorphic Crystalline Structures of Polyethylenes with Halogens Placed at Equal Distance along the Backbone.

Zhang X, Santonja-Blasco L, Wagener KB, Boz E, Tasaki M, Tashiro K, Alamo RG.

J Phys Chem B. 2017 Nov 2;121(43):10166-10179. doi: 10.1021/acs.jpcb.7b08877. Epub 2017 Oct 23.

PMID:
29016133
44.

A novel transthyretin variant V28S (p.V48S) with a double-nucleotide substitution in the same codon.

Okada M, Misumi Y, Ueda M, Yamashita T, Masuda T, Tasaki M, Ando Y.

Amyloid. 2017 Dec;24(4):231-232. doi: 10.1080/13506129.2017.1381082. Epub 2017 Sep 26. No abstract available.

PMID:
28949257
45.

The sp7 gene is required for maturation of osteoblast-lineage cells in medaka (Oryzias latipes) vertebral column development.

Azetsu Y, Inohaya K, Takano Y, Kinoshita M, Tasaki M, Kudo A.

Dev Biol. 2017 Nov 15;431(2):252-262. doi: 10.1016/j.ydbio.2017.09.010. Epub 2017 Sep 9.

46.

Serum amyloid P component: A novel potential player in vessel degeneration in CADASIL.

Nagatoshi A, Ueda M, Ueda A, Tasaki M, Inoue Y, Ma Y, Masuda T, Mizukami M, Matsumoto S, Kosaka T, Kawano T, Ito T, Ando Y.

J Neurol Sci. 2017 Aug 15;379:69-76. doi: 10.1016/j.jns.2017.05.033. Epub 2017 May 26.

PMID:
28716282
47.

Analysis of deposited peptides in amyloid lesions of AL amyloidosis by mass spectrometry.

Sugimoto T, Tasaki M, Yamashita T, Ueda M, Ando Y, Obayashi K, Okuno Y, Hata H.

Rinsho Ketsueki. 2017;58(6):589-594. doi: 10.11406/rinketsu.58.589. Japanese.

PMID:
28679987
48.

Early skin denervation in hereditary and iatrogenic transthyretin amyloid neuropathy.

Masuda T, Ueda M, Suenaga G, Misumi Y, Tasaki M, Izaki A, Yanagisawa Y, Inoue Y, Motokawa H, Matsumoto S, Mizukami M, Arimura A, Deguchi T, Nishio Y, Yamashita T, Inomata Y, Obayashi K, Ando Y.

Neurology. 2017 Jun 6;88(23):2192-2197. doi: 10.1212/WNL.0000000000004016. Epub 2017 May 10.

PMID:
28490654
49.

Sushi repeat-containing protein 1: a novel disease-associated molecule in cerebral amyloid angiopathy.

Inoue Y, Ueda M, Tasaki M, Takeshima A, Nagatoshi A, Masuda T, Misumi Y, Kosaka T, Nomura T, Mizukami M, Matsumoto S, Yamashita T, Takahashi H, Kakita A, Ando Y.

Acta Neuropathol. 2017 Oct;134(4):605-617. doi: 10.1007/s00401-017-1720-z. Epub 2017 May 6.

PMID:
28478503
50.

A late-onset case of hereditary transthyretin amyloidosis with a novel compound heterozygous mutation.

Matsumoto S, Ueda M, Yamashita T, Amano T, Misumi Y, Tasaki M, Masuda T, Mizukami M, Furuya H, Ando Y.

Amyloid. 2017 Mar;24(sup1):97-98. doi: 10.1080/13506129.2017.1286585. No abstract available.

PMID:
28434367

Supplemental Content

Loading ...
Support Center